HCV infection in very-long-term survivors after cancer chemotherapy and bone marrow transplantation: A single-center experience

Journal of Pediatric Hematology/Oncology

Volumn 27, Issue 9, 2005, Pages 481-485

  Fioredda, Francesca ^a   Gigliotti, Anna Rita ^a   Haupt, Riccardo ^a   Calevo, Maria Grazia ^a   Lo Giudice, Cinzia ^a   Bocciardo, Laura ^a   Giacchino, Raffaella ^a  

^a G GASLINI INSTITUTE   (Italy)

Author keywords

Chronic hepatitis C; Long term survivors

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA2 INTERFERON; ANTIMETABOLITE; ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; IFOSFAMIDE; IMMUNOSUPPRESSIVE AGENT; MELPHALAN; MERCAPTOPURINE; METHOTREXATE; RIBAVIRIN; STEROID; TIOGUANINE; VIRUS RNA;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; BONE MARROW TRANSPLANTATION; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; COHORT ANALYSIS; CYTOLYSIS; DISEASE COURSE; EWING SARCOMA; FEMALE; FOLLOW UP; HEPATITIS C; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFANT; LIVER FIBROSIS; LIVER INJURY; LIVER TOXICITY; MALE; NEPHROBLASTOMA; NEUROBLASTOMA; OUTCOMES RESEARCH; PATIENT REFERRAL; PRIORITY JOURNAL; RISK FACTOR;

ADOLESCENT; ADULT; ANTINEOPLASTIC AGENTS; BONE MARROW TRANSPLANTATION; CHILD; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HEPATITIS C, CHRONIC; HUMANS; LONGITUDINAL STUDIES; MALE; NEOPLASMS; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SURVIVORS; TREATMENT OUTCOME;

EID: 25844503721     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mph.0000179959.27148.85     Document Type: Article

References (27)

1. Leung NW. Management of viral hepatitis C. J Gastroenterol Hepatol. 2002;17:46-54.
2. Jara P, Resti M, Hierro L, et al. Chronic hepatitis C virus infection in childhood: clinical patterns and evolution in 224 white children. Clin Infect Dis. 2003;1:275-280.
3. Gigliotti AR, Fioredda F, Giacchino R. Hepatitis B and C infection in children undergoing chemotherapy or bone marrow transplantation. J Pediatr Hematol Oncol. 2003;3:184-192.
4. Alberti A, Benvegnu L. Management of hepatitis C. J Hepatol. 2003;38: S104-S118.
5. Cerny A, Chisari FV. Pathogenesis of chronic hepatitis C: immunological features of hepatic injury and viral persistence. Hepatology. 1999;30:595-601.
6. Strickland DK, Riely CA, Patrick CC, et al. Hepatitis C infection among survivors of childhood cancer. Blood. 2000;95:3065-3070.
7. Castellino S, Lensing S, Riely C, et al. The epidemiology of chronic hepatitis C infection in survivors of childhood cancer, an update of the St. Jude Children's Research Hospital hepatitis C seropositive cohort. Blood. 2004;103:2460-2466.
8. Strasser SI, Sullivan KM, Myerson D, et al. Cirrhosis of the liver in long-term marrow transplant survivors. Blood. 1999;5:3259-3266.
9. De Latour RP, Levy V, Asselah T, et al. Long-term outcome of hepatitis C infection after bone marrow transplantation. Blood. 2004;103:1618-1624.
10. Dreyer ZE, Blatt J, Bleyer WA. Late effects of childhood cancer and its treatment. In: Pizzo PA, Poplack DG, eds. Principles and Practice of Pediatric Oncology, 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2001:1431-1462.
11. Simmonds P, Holmes EC, Cha TA, et al. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol. 1993;74:2391-2399.
12. Scheuer PJ. Classification of chronic viral hepatitis: a need for reassessment. J Hepatol. 1991;13:372-374.
13. Guido M, Faa G. Morphological diagnosis of chronic hepatitis. Minimal requirements for histopathological referral. Pathologica. 1998;90:176-182.
14. Booth JCL, O'Grady J, Neuberger J. Clinical guidelines on the management of hepatitis C. Gut. 2001;49:i1-i21.
15. Lauer GM, Walker BD. Hepatitis C virus infection. N Engl J Med. 2001;5: 41-52.
16. Paul IM, Sanders J, Ruggiero F, et al. Chronic hepatitis C virus infections in leukaemia survivors: prevalence, viral load, and severity of liver disease. Blood. 1999;93:3672-3677.
17. Locasciulli A, Testa M, Pontisso P, et al. Prevalence and natural history of hepatitis C infection in patients cured of childhood leukemia. Blood. 1997;90:4628-4633.
18. Arico' M, Maggiore G, Silini E, et al. Hepatitis C virus infection in children treated for acute lymphoblastic leukemia. Blood. 1994;84:2919-2922.
19. Cesaro S, Petris MG, Rossetti F, et al. Chronic hepatitis C virus infection after treatment for paediatric malignancy. Blood. 1997;90:1315-1320.
20. Palomba E, Manzini P, Fiammengo P, et al. Natural history of perinatal hepatitis C virus infection. Clin Infect Dis. 1996;23:47-50.
21. Bortolotti F, Resti M, Giacchino R, et al. Hepatitis C virus infection and related liver disease in children of mothers with antibodies to the virus. J Pediatr. 1997;130:990-993.
22. Tovo P-A, Pembrey LJ, Newell M-L. Persistence rate and progression of vertically acquired hepatitis C infection. J Infect Dis. 2000;181:419-424.
23. Resti M, Jara P, Hierro L, et al. Clinical features and progression of perinatally acquired hepatitis C virus infection. J Med Virol. 2003;70: 373-377.
24. Ni YH, Chang MH, Lue HC, et al. Post-transfusion hepatitis C infection in children. Pediatrics. 1994;124:709-713.
25. Vogt M, Lang T, Frosner G, et al. Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood donor screening. N Engl J Med. 1999;341: 866-870.
26. Casiraghi MA, De-Pascale M, Romano L, et al. Long term outcome (35 years) of hepatitis C after acquisition of infection through mini transfusion of blood given at birth. Hepatology. 2004;39:90-96.
27. Andriulli A, Persico M, Iacobellis A, et al. Treatment of patients with HCV infection with or without liver biopsy. J Viral Hepatol. 2004;11: 536-542.